

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.39164813 |
| 2 | complement activation, alternative pathway (GO:0006957) | 4.42014113 |
| 3 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.29993814 |
| 4 | negative regulation of smooth muscle cell migration (GO:0014912) | 4.27386024 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.25240188 |
| 6 | regulation of protein activation cascade (GO:2000257) | 4.14810348 |
| 7 | extracellular matrix assembly (GO:0085029) | 4.14009190 |
| 8 | protein heterotrimerization (GO:0070208) | 4.08823115 |
| 9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.04796431 |
| 10 | protein carboxylation (GO:0018214) | 4.04796431 |
| 11 | regulation of complement activation (GO:0030449) | 3.96849995 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 3.88952069 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 3.88906756 |
| 14 | low-density lipoprotein particle remodeling (GO:0034374) | 3.85860524 |
| 15 | endodermal cell differentiation (GO:0035987) | 3.83676815 |
| 16 | bile acid biosynthetic process (GO:0006699) | 3.74996210 |
| 17 | L-phenylalanine catabolic process (GO:0006559) | 3.72767916 |
| 18 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.72767916 |
| 19 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.71463236 |
| 20 | high-density lipoprotein particle remodeling (GO:0034375) | 3.69899300 |
| 21 | regulation of fibrinolysis (GO:0051917) | 3.68780937 |
| 22 | aromatic amino acid family catabolic process (GO:0009074) | 3.67916490 |
| 23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.61472511 |
| 24 | collagen fibril organization (GO:0030199) | 3.60833372 |
| 25 | urea metabolic process (GO:0019627) | 3.58649206 |
| 26 | urea cycle (GO:0000050) | 3.58649206 |
| 27 | hypotonic response (GO:0006971) | 3.57856959 |
| 28 | plasma lipoprotein particle remodeling (GO:0034369) | 3.56123805 |
| 29 | protein-lipid complex remodeling (GO:0034368) | 3.56123805 |
| 30 | macromolecular complex remodeling (GO:0034367) | 3.56123805 |
| 31 | indole-containing compound catabolic process (GO:0042436) | 3.54673456 |
| 32 | indolalkylamine catabolic process (GO:0046218) | 3.54673456 |
| 33 | tryptophan catabolic process (GO:0006569) | 3.54673456 |
| 34 | phospholipid efflux (GO:0033700) | 3.53678388 |
| 35 | pinocytosis (GO:0006907) | 3.50186264 |
| 36 | regulation of macrophage cytokine production (GO:0010935) | 3.50070161 |
| 37 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.48681571 |
| 38 | positive regulation by symbiont of host defense response (GO:0052509) | 3.46970761 |
| 39 | modulation by symbiont of host defense response (GO:0052031) | 3.46970761 |
| 40 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.46970761 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.46970761 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.46970761 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.46970761 |
| 44 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.44473030 |
| 45 | L-phenylalanine metabolic process (GO:0006558) | 3.44473030 |
| 46 | reverse cholesterol transport (GO:0043691) | 3.43609221 |
| 47 | type B pancreatic cell proliferation (GO:0044342) | 3.42169810 |
| 48 | collagen metabolic process (GO:0032963) | 3.40040992 |
| 49 | skin morphogenesis (GO:0043589) | 3.39778135 |
| 50 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.39729636 |
| 51 | tryptophan metabolic process (GO:0006568) | 3.38978971 |
| 52 | blood vessel maturation (GO:0001955) | 3.38433829 |
| 53 | apoptotic cell clearance (GO:0043277) | 3.37638008 |
| 54 | definitive hemopoiesis (GO:0060216) | 3.36493439 |
| 55 | bone trabecula formation (GO:0060346) | 3.33931233 |
| 56 | regulation of cholesterol esterification (GO:0010872) | 3.33890914 |
| 57 | lung vasculature development (GO:0060426) | 3.31849742 |
| 58 | collagen catabolic process (GO:0030574) | 3.30909509 |
| 59 | phospholipid homeostasis (GO:0055091) | 3.27948303 |
| 60 | plasma lipoprotein particle clearance (GO:0034381) | 3.27925702 |
| 61 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.27526871 |
| 62 | chondroitin sulfate biosynthetic process (GO:0030206) | 3.27234135 |
| 63 | regulation of response to osmotic stress (GO:0047484) | 3.24388975 |
| 64 | extracellular fibril organization (GO:0043206) | 3.21788499 |
| 65 | nitrogen cycle metabolic process (GO:0071941) | 3.21725031 |
| 66 | cell migration involved in heart development (GO:0060973) | 3.21442885 |
| 67 | positive regulation of blood coagulation (GO:0030194) | 3.20199363 |
| 68 | positive regulation of hemostasis (GO:1900048) | 3.20199363 |
| 69 | regulation of triglyceride catabolic process (GO:0010896) | 3.20019286 |
| 70 | adhesion of symbiont to host cell (GO:0044650) | 3.19758061 |
| 71 | virion attachment to host cell (GO:0019062) | 3.19758061 |
| 72 | sulfur amino acid catabolic process (GO:0000098) | 3.19510039 |
| 73 | keratan sulfate catabolic process (GO:0042340) | 3.18477664 |
| 74 | kynurenine metabolic process (GO:0070189) | 3.17727728 |
| 75 | positive regulation of macrophage cytokine production (GO:0060907) | 3.16253626 |
| 76 | plasma lipoprotein particle assembly (GO:0034377) | 3.15940452 |
| 77 | fibril organization (GO:0097435) | 3.15874159 |
| 78 | glyoxylate metabolic process (GO:0046487) | 3.13742079 |
| 79 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.12431968 |
| 80 | acute-phase response (GO:0006953) | 3.12029999 |
| 81 | positive regulation of coagulation (GO:0050820) | 3.11536125 |
| 82 | opsonization (GO:0008228) | 3.11506300 |
| 83 | response to interferon-beta (GO:0035456) | 3.11056220 |
| 84 | positive regulation of B cell differentiation (GO:0045579) | 3.10771186 |
| 85 | basement membrane organization (GO:0071711) | 3.10749445 |
| 86 | multicellular organismal macromolecule metabolic process (GO:0044259) | 3.10475906 |
| 87 | bile acid metabolic process (GO:0008206) | 3.08677400 |
| 88 | adhesion of symbiont to host (GO:0044406) | 3.08117246 |
| 89 | fibrinolysis (GO:0042730) | 3.07553692 |
| 90 | chondrocyte proliferation (GO:0035988) | 3.06330799 |
| 91 | negative regulation of biomineral tissue development (GO:0070168) | 3.05636217 |
| 92 | cholesterol efflux (GO:0033344) | 3.04982397 |
| 93 | regulation of smooth muscle cell migration (GO:0014910) | 3.04858549 |
| 94 | plasma lipoprotein particle organization (GO:0071827) | 3.02918237 |
| 95 | cell adhesion mediated by integrin (GO:0033627) | 3.00827934 |
| 96 | blood coagulation, intrinsic pathway (GO:0007597) | 2.99205561 |
| 97 | aldehyde catabolic process (GO:0046185) | 2.99198707 |
| 98 | neutrophil activation involved in immune response (GO:0002283) | 2.99039386 |
| 99 | myeloid leukocyte mediated immunity (GO:0002444) | 2.98940842 |
| 100 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.98811578 |
| 101 | multicellular organismal catabolic process (GO:0044243) | 2.97868906 |
| 102 | hyaluronan catabolic process (GO:0030214) | 2.97702418 |
| 103 | homocysteine metabolic process (GO:0050667) | 2.96468891 |
| 104 | negative regulation of fatty acid transport (GO:2000192) | 2.95382884 |
| 105 | protein activation cascade (GO:0072376) | 2.95094293 |
| 106 | response to peptidoglycan (GO:0032494) | 2.94499104 |
| 107 | imidazole-containing compound metabolic process (GO:0052803) | 2.93969386 |
| 108 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.93896090 |
| 109 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.93896090 |
| 110 | regulation of growth of symbiont in host (GO:0044126) | 2.93896090 |
| 111 | negative regulation of growth of symbiont in host (GO:0044130) | 2.93896090 |
| 112 | mannose metabolic process (GO:0006013) | 2.93604488 |
| 113 | regulation of humoral immune response (GO:0002920) | 2.92624234 |
| 114 | positive regulation of lipid catabolic process (GO:0050996) | 2.92312782 |
| 115 | * mesenchymal-epithelial cell signaling (GO:0060638) | 2.91536801 |
| 116 | multicellular organismal metabolic process (GO:0044236) | 2.91524010 |
| 117 | cortical actin cytoskeleton organization (GO:0030866) | 2.91199625 |
| 118 | protein-lipid complex assembly (GO:0065005) | 2.90722735 |
| 119 | response to interferon-alpha (GO:0035455) | 2.89625941 |
| 120 | protein-lipid complex subunit organization (GO:0071825) | 2.89115834 |
| 121 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.87025049 |
| 122 | extracellular matrix disassembly (GO:0022617) | 2.85304845 |
| 123 | neutrophil mediated immunity (GO:0002446) | 2.84737545 |
| 124 | regulation of apoptotic cell clearance (GO:2000425) | 2.83486829 |
| 125 | immunoglobulin mediated immune response (GO:0016064) | 2.83348821 |
| 126 | regulation of chemokine biosynthetic process (GO:0045073) | 2.83225393 |
| 127 | cysteine metabolic process (GO:0006534) | 2.83092781 |
| 128 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.81691920 |
| 129 | complement activation (GO:0006956) | 2.81313723 |
| 130 | positive regulation of extracellular matrix organization (GO:1903055) | 2.81047561 |
| 131 | positive regulation of phagocytosis (GO:0050766) | 2.80921516 |
| 132 | lipoprotein metabolic process (GO:0042157) | 2.80740597 |
| 133 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.79943379 |
| 134 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.79288573 |
| 135 | detection of molecule of bacterial origin (GO:0032490) | 2.78207672 |
| 136 | NAD biosynthetic process (GO:0009435) | 2.76986529 |
| 137 | phagocytosis, engulfment (GO:0006911) | 2.76795348 |
| 138 | response to muramyl dipeptide (GO:0032495) | 2.76293643 |
| 139 | positive regulation of interferon-alpha production (GO:0032727) | 2.76117780 |
| 140 | microglial cell activation (GO:0001774) | 2.75296767 |
| 141 | cellular response to vitamin (GO:0071295) | 2.74370230 |
| 142 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.73660121 |
| 143 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.73660121 |
| 144 | UV protection (GO:0009650) | 2.73230558 |
| 145 | mature B cell differentiation involved in immune response (GO:0002313) | 2.71921609 |
| 146 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.71542566 |
| 147 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.71542566 |
| 148 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.67672723 |
| 149 | respiratory tube development (GO:0030323) | 2.66943401 |
| 150 | platelet dense granule organization (GO:0060155) | 2.66888641 |
| 151 | cellular glucuronidation (GO:0052695) | 2.66768405 |
| 152 | negative regulation of cholesterol transport (GO:0032375) | 2.65625428 |
| 153 | negative regulation of sterol transport (GO:0032372) | 2.65625428 |
| 154 | mesodermal cell differentiation (GO:0048333) | 2.65230097 |
| 155 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 2.64613597 |
| 156 | pyridine nucleotide biosynthetic process (GO:0019363) | 2.64613597 |
| 157 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.64321825 |
| 158 | amino-acid betaine metabolic process (GO:0006577) | 2.63366232 |
| 159 | macrophage activation involved in immune response (GO:0002281) | 2.62428137 |
| 160 | bile acid and bile salt transport (GO:0015721) | 2.61976124 |
| 161 | detection of external biotic stimulus (GO:0098581) | 2.61707021 |
| 162 | cellular extravasation (GO:0045123) | 2.61569756 |
| 163 | regulation of leukocyte degranulation (GO:0043300) | 2.60153802 |
| 164 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.59631913 |
| 165 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 2.56606563 |
| 166 | negative regulation of interleukin-8 production (GO:0032717) | 2.56476369 |
| 167 | phagocytosis, recognition (GO:0006910) | 2.55460258 |
| 168 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.54405472 |
| 169 | tooth mineralization (GO:0034505) | 2.54313239 |
| 170 | cortical cytoskeleton organization (GO:0030865) | 2.51781389 |
| 171 | glial cell migration (GO:0008347) | 2.51117357 |
| 172 | lung lobe morphogenesis (GO:0060463) | 2.50684002 |
| 173 | regulation of phagocytosis (GO:0050764) | 2.49404814 |
| 174 | substrate-dependent cell migration (GO:0006929) | 2.48848848 |
| 175 | dermatan sulfate metabolic process (GO:0030205) | 2.47534998 |
| 176 | dermatan sulfate biosynthetic process (GO:0030208) | 2.47369327 |
| 177 | regulation of mast cell degranulation (GO:0043304) | 2.45710591 |
| 178 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.45099659 |
| 179 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.41810212 |
| 180 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.40630677 |
| 181 | barbed-end actin filament capping (GO:0051016) | 2.39855707 |
| 182 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.39773337 |
| 183 | positive regulation of osteoblast proliferation (GO:0033690) | 2.39583141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.73760961 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.10562486 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.06781677 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.77003387 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.55090528 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.00460849 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.90936527 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.73300050 |
| 9 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.36670171 |
| 10 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.28461296 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.11697487 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.05425431 |
| 13 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.02650180 |
| 14 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02246721 |
| 15 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.83478928 |
| 16 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.83140244 |
| 17 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.82502101 |
| 18 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.82261004 |
| 19 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.78074911 |
| 20 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.76831012 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.70027268 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.61131981 |
| 23 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.58220605 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24501581 |
| 25 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.21699847 |
| 26 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.20255688 |
| 27 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.08055639 |
| 28 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.07869123 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.07448758 |
| 30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.05256695 |
| 31 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 2.04469064 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 2.02643393 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01362369 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97115764 |
| 35 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.97048480 |
| 36 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.93184610 |
| 37 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.84521545 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82949184 |
| 39 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.82890124 |
| 40 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.80633405 |
| 41 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.78567014 |
| 42 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.73029691 |
| 43 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66847699 |
| 44 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.64602764 |
| 45 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63251020 |
| 46 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59382753 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.57815237 |
| 48 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54553889 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53113807 |
| 50 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.49731666 |
| 51 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48888190 |
| 52 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.43558150 |
| 53 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.42579121 |
| 54 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.41829453 |
| 55 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.41828335 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.37612233 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37573252 |
| 58 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.37468971 |
| 59 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37461608 |
| 60 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.36775570 |
| 61 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36748395 |
| 62 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.36477018 |
| 63 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.35050193 |
| 64 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33396724 |
| 65 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30762769 |
| 66 | MYC_22102868_ChIP-Seq_BL_Human | 1.29334211 |
| 67 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.28357910 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28319038 |
| 69 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.27815372 |
| 70 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26792036 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25542259 |
| 72 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24820255 |
| 73 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.24510621 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.24252293 |
| 75 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23795806 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23541123 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.23405765 |
| 78 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.22928751 |
| 79 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.19598137 |
| 80 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.19386498 |
| 81 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.17231771 |
| 82 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.15251756 |
| 83 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.14503631 |
| 84 | * MYB_26560356_Chip-Seq_TH2_Human | 1.14404243 |
| 85 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.12514862 |
| 86 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12247660 |
| 87 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12247660 |
| 88 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.12027831 |
| 89 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10358610 |
| 90 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.10221783 |
| 91 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.09675883 |
| 92 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.09387325 |
| 93 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09311617 |
| 94 | MYB_26560356_Chip-Seq_TH1_Human | 1.08340535 |
| 95 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08322569 |
| 96 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.07698426 |
| 97 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.06996843 |
| 98 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.04742810 |
| 99 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.04742810 |
| 100 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04670137 |
| 101 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.04227296 |
| 102 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.03767512 |
| 103 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02955726 |
| 104 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.01563794 |
| 105 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.01105955 |
| 106 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00883197 |
| 107 | SPI1_23127762_ChIP-Seq_K562_Human | 1.00831783 |
| 108 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.99878871 |
| 109 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99810865 |
| 110 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.97673962 |
| 111 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97248602 |
| 112 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.96098152 |
| 113 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.95517548 |
| 114 | * TP53_16413492_ChIP-PET_HCT116_Human | 0.94496337 |
| 115 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93929737 |
| 116 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.92036394 |
| 117 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91895871 |
| 118 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.91633741 |
| 119 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.91616095 |
| 120 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89029347 |
| 121 | MAF_26560356_Chip-Seq_TH1_Human | 0.86958035 |
| 122 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86929626 |
| 123 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84132552 |
| 124 | GATA3_26560356_Chip-Seq_TH2_Human | 0.83684008 |
| 125 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82868870 |
| 126 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81104416 |
| 127 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.81031664 |
| 128 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.80906509 |
| 129 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.80492841 |
| 130 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78020507 |
| 131 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.77611800 |
| 132 | CJUN_26792858_Chip-Seq_BT549_Human | 0.76943530 |
| 133 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76905721 |
| 134 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.74651272 |
| 135 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.74621103 |
| 136 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.73502614 |
| 137 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.70746484 |
| 138 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.68091272 |
| 139 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.67904000 |
| 140 | GATA1_19941826_ChIP-Seq_K562_Human | 0.66312000 |
| 141 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.65866966 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 4.22062918 |
| 2 | MP0005360_urolithiasis | 3.89369801 |
| 3 | MP0005365_abnormal_bile_salt | 3.42409326 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.24707686 |
| 5 | MP0003436_decreased_susceptibility_to | 2.96854197 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.83645488 |
| 7 | MP0009840_abnormal_foam_cell | 2.80333312 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.62751390 |
| 9 | MP0003252_abnormal_bile_duct | 2.58461743 |
| 10 | MP0003724_increased_susceptibility_to | 2.56352416 |
| 11 | MP0005464_abnormal_platelet_physiology | 2.39746268 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.36851365 |
| 13 | MP0009785_altered_susceptibility_to | 2.33681230 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.30359241 |
| 15 | MP0010329_abnormal_lipoprotein_level | 2.28641123 |
| 16 | MP0002419_abnormal_innate_immunity | 2.25135678 |
| 17 | MP0001542_abnormal_bone_strength | 2.23482122 |
| 18 | MP0005058_abnormal_lysosome_morphology | 2.09052192 |
| 19 | MP0004272_abnormal_basement_membrane | 2.07697895 |
| 20 | MP0005083_abnormal_biliary_tract | 1.97683549 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 1.91168815 |
| 22 | MP0005025_abnormal_response_to | 1.90606134 |
| 23 | MP0006082_CNS_inflammation | 1.84948803 |
| 24 | MP0009764_decreased_sensitivity_to | 1.84021614 |
| 25 | MP0003279_aneurysm | 1.80339062 |
| 26 | MP0003806_abnormal_nucleotide_metabolis | 1.78345650 |
| 27 | MP0002396_abnormal_hematopoietic_system | 1.75882854 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.65982874 |
| 29 | MP0003091_abnormal_cell_migration | 1.63286088 |
| 30 | MP0003195_calcinosis | 1.61700858 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.58699422 |
| 32 | MP0000685_abnormal_immune_system | 1.58552421 |
| 33 | MP0008469_abnormal_protein_level | 1.56853367 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.56358995 |
| 35 | MP0003172_abnormal_lysosome_physiology | 1.54203140 |
| 36 | MP0001853_heart_inflammation | 1.54120220 |
| 37 | MP0001545_abnormal_hematopoietic_system | 1.53775469 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.53775469 |
| 39 | MP0003303_peritoneal_inflammation | 1.51622826 |
| 40 | MP0001986_abnormal_taste_sensitivity | 1.51428542 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.49085103 |
| 42 | * MP0000609_abnormal_liver_physiology | 1.47915610 |
| 43 | MP0005508_abnormal_skeleton_morphology | 1.46791687 |
| 44 | MP0003868_abnormal_feces_composition | 1.45662869 |
| 45 | MP0003705_abnormal_hypodermis_morpholog | 1.45036465 |
| 46 | MP0006054_spinal_hemorrhage | 1.44923816 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.44125136 |
| 48 | MP0000569_abnormal_digit_pigmentation | 1.42692039 |
| 49 | MP0009278_abnormal_bone_marrow | 1.42619473 |
| 50 | MP0009697_abnormal_copulation | 1.41493999 |
| 51 | MP0002452_abnormal_antigen_presenting | 1.40014375 |
| 52 | MP0003448_altered_tumor_morphology | 1.38666007 |
| 53 | MP0002254_reproductive_system_inflammat | 1.36414340 |
| 54 | MP0000465_gastrointestinal_hemorrhage | 1.36156251 |
| 55 | MP0005171_absent_coat_pigmentation | 1.36041261 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.35694089 |
| 57 | MP0009763_increased_sensitivity_to | 1.33777923 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.33048312 |
| 59 | MP0002723_abnormal_immune_serum | 1.32000748 |
| 60 | MP0001800_abnormal_humoral_immune | 1.31085108 |
| 61 | MP0002295_abnormal_pulmonary_circulatio | 1.31077695 |
| 62 | MP0003075_altered_response_to | 1.30587729 |
| 63 | MP0000343_altered_response_to | 1.29833320 |
| 64 | MP0005332_abnormal_amino_acid | 1.29830663 |
| 65 | MP0001666_abnormal_nutrient_absorption | 1.28488952 |
| 66 | MP0005319_abnormal_enzyme/_coenzyme | 1.27205860 |
| 67 | MP0001845_abnormal_inflammatory_respons | 1.26302434 |
| 68 | MP0004883_abnormal_blood_vessel | 1.25494777 |
| 69 | MP0000858_altered_metastatic_potential | 1.25478183 |
| 70 | MP0004808_abnormal_hematopoietic_stem | 1.21593738 |
| 71 | MP0002118_abnormal_lipid_homeostasis | 1.20246800 |
| 72 | MP0002006_tumorigenesis | 1.19469675 |
| 73 | MP0005275_abnormal_skin_tensile | 1.16690480 |
| 74 | MP0005076_abnormal_cell_differentiation | 1.15416055 |
| 75 | MP0003950_abnormal_plasma_membrane | 1.15399097 |
| 76 | MP0001819_abnormal_immune_cell | 1.13598659 |
| 77 | MP0002420_abnormal_adaptive_immunity | 1.13231249 |
| 78 | MP0000767_abnormal_smooth_muscle | 1.12712885 |
| 79 | MP0000598_abnormal_liver_morphology | 1.12676042 |
| 80 | MP0000751_myopathy | 1.12616971 |
| 81 | MP0005671_abnormal_response_to | 1.12504114 |
| 82 | MP0002009_preneoplasia | 1.12011235 |
| 83 | MP0003690_abnormal_glial_cell | 1.11504405 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 1.10759923 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.08503902 |
| 86 | MP0001790_abnormal_immune_system | 1.08272216 |
| 87 | MP0005387_immune_system_phenotype | 1.08272216 |
| 88 | MP0003186_abnormal_redox_activity | 1.07291932 |
| 89 | MP0002896_abnormal_bone_mineralization | 1.06923032 |
| 90 | MP0005023_abnormal_wound_healing | 1.06904987 |
| 91 | MP0005595_abnormal_vascular_smooth | 1.06828397 |
| 92 | MP0001958_emphysema | 1.06317783 |
| 93 | MP0002108_abnormal_muscle_morphology | 1.06300735 |
| 94 | MP0009384_cardiac_valve_regurgitation | 1.04491803 |
| 95 | MP0005174_abnormal_tail_pigmentation | 1.02810512 |
| 96 | MP0002998_abnormal_bone_remodeling | 1.01339132 |
| 97 | MP0010386_abnormal_urinary_bladder | 1.00246886 |
| 98 | MP0001243_abnormal_dermal_layer | 1.00011166 |
| 99 | MP0010368_abnormal_lymphatic_system | 0.99976249 |
| 100 | MP0002405_respiratory_system_inflammati | 0.97552008 |
| 101 | MP0004947_skin_inflammation | 0.96676981 |
| 102 | MP0004019_abnormal_vitamin_homeostasis | 0.96155801 |
| 103 | MP0001764_abnormal_homeostasis | 0.95660850 |
| 104 | MP0005623_abnormal_meninges_morphology | 0.94582938 |
| 105 | MP0005166_decreased_susceptibility_to | 0.94101405 |
| 106 | MP0005390_skeleton_phenotype | 0.91420882 |
| 107 | MP0000604_amyloidosis | 0.91351919 |
| 108 | MP0003795_abnormal_bone_structure | 0.90642310 |
| 109 | MP0002060_abnormal_skin_morphology | 0.89895641 |
| 110 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.89398587 |
| 111 | MP0003828_pulmonary_edema | 0.88821688 |
| 112 | MP0002168_other_aberrant_phenotype | 0.86950663 |
| 113 | MP0000689_abnormal_spleen_morphology | 0.86511613 |
| 114 | MP0000733_abnormal_muscle_development | 0.86472194 |
| 115 | MP0008004_abnormal_stomach_pH | 0.86431350 |
| 116 | MP0005164_abnormal_response_to | 0.85962403 |
| 117 | MP0000716_abnormal_immune_system | 0.85420901 |
| 118 | MP0003045_fibrosis | 0.84915157 |
| 119 | MP0005503_abnormal_tendon_morphology | 0.84770868 |
| 120 | MP0002398_abnormal_bone_marrow | 0.81099303 |
| 121 | MP0001915_intracranial_hemorrhage | 0.80596864 |
| 122 | MP0000249_abnormal_blood_vessel | 0.80592690 |
| 123 | MP0002933_joint_inflammation | 0.80110428 |
| 124 | MP0003011_delayed_dark_adaptation | 0.78256227 |
| 125 | MP0009765_abnormal_xenobiotic_induced | 0.78179134 |
| 126 | MP0001661_extended_life_span | 0.77409247 |
| 127 | MP0008874_decreased_physiological_sensi | 0.76504266 |
| 128 | MP0010352_gastrointestinal_tract_polyps | 0.75920709 |
| 129 | MP0003943_abnormal_hepatobiliary_system | 0.75847941 |
| 130 | * MP0002429_abnormal_blood_cell | 0.75036754 |
| 131 | MP0005165_increased_susceptibility_to | 0.72048735 |
| 132 | MP0004130_abnormal_muscle_cell | 0.71917051 |
| 133 | MP0005220_abnormal_exocrine_pancreas | 0.71675921 |
| 134 | MP0009643_abnormal_urine_homeostasis | 0.71354874 |
| 135 | MP0003763_abnormal_thymus_physiology | 0.69980169 |
| 136 | MP0004134_abnormal_chest_morphology | 0.69881131 |
| 137 | MP0000681_abnormal_thyroid_gland | 0.68139443 |
| 138 | MP0005451_abnormal_body_composition | 0.65645667 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ankle contracture (HP:0006466) | 4.79757575 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.73894523 |
| 3 | Follicular hyperkeratosis (HP:0007502) | 4.72929833 |
| 4 | Aortic aneurysm (HP:0004942) | 4.67166973 |
| 5 | Aortic dissection (HP:0002647) | 4.61073761 |
| 6 | Joint hemorrhage (HP:0005261) | 4.60693893 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.59920268 |
| 8 | Complement deficiency (HP:0004431) | 4.59583582 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 4.34945330 |
| 10 | Intrahepatic cholestasis (HP:0001406) | 4.32213479 |
| 11 | Spondylolisthesis (HP:0003302) | 4.26505883 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.24798602 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.22857524 |
| 14 | Xanthomatosis (HP:0000991) | 4.18707587 |
| 15 | Type 1 muscle fiber predominance (HP:0003803) | 4.16559973 |
| 16 | Soft skin (HP:0000977) | 3.89652386 |
| 17 | Vascular tortuosity (HP:0004948) | 3.89309307 |
| 18 | Slender build (HP:0001533) | 3.87588714 |
| 19 | Abnormality of complement system (HP:0005339) | 3.81803554 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.76935312 |
| 21 | Recurrent abscess formation (HP:0002722) | 3.67117789 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.65486421 |
| 23 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.64680956 |
| 24 | Gingival bleeding (HP:0000225) | 3.63666572 |
| 25 | Arterial tortuosity (HP:0005116) | 3.62183172 |
| 26 | Wormian bones (HP:0002645) | 3.56428905 |
| 27 | Hypobetalipoproteinemia (HP:0003563) | 3.53767415 |
| 28 | Hyperlipoproteinemia (HP:0010980) | 3.41874471 |
| 29 | Eczematoid dermatitis (HP:0000976) | 3.38721841 |
| 30 | Glomerulonephritis (HP:0000099) | 3.23788735 |
| 31 | Bladder diverticulum (HP:0000015) | 3.19203238 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.15543114 |
| 33 | Myocardial infarction (HP:0001658) | 3.14191543 |
| 34 | Increased variability in muscle fiber diameter (HP:0003557) | 3.14025126 |
| 35 | Genu recurvatum (HP:0002816) | 3.05466749 |
| 36 | Absent frontal sinuses (HP:0002688) | 3.04918114 |
| 37 | Epidermoid cyst (HP:0200040) | 3.04776576 |
| 38 | Epistaxis (HP:0000421) | 3.03085203 |
| 39 | Spinal rigidity (HP:0003306) | 2.98423481 |
| 40 | Dilatation of the ascending aorta (HP:0005111) | 2.97539129 |
| 41 | Broad metatarsal (HP:0001783) | 2.95809534 |
| 42 | Cerebral aneurysm (HP:0004944) | 2.93958307 |
| 43 | Hypercholesterolemia (HP:0003124) | 2.93257360 |
| 44 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.93044796 |
| 45 | Hypolipoproteinemia (HP:0010981) | 2.92758726 |
| 46 | Abnormality of dentin (HP:0010299) | 2.89758776 |
| 47 | Blue sclerae (HP:0000592) | 2.89472465 |
| 48 | Overgrowth (HP:0001548) | 2.89130877 |
| 49 | Prolonged bleeding time (HP:0003010) | 2.88883356 |
| 50 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.87032415 |
| 51 | Menorrhagia (HP:0000132) | 2.85900151 |
| 52 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.82408082 |
| 53 | Vacuolated lymphocytes (HP:0001922) | 2.82059222 |
| 54 | Hypoalphalipoproteinemia (HP:0003233) | 2.81820501 |
| 55 | Protrusio acetabuli (HP:0003179) | 2.81585479 |
| 56 | Peritonitis (HP:0002586) | 2.79068731 |
| 57 | Myositis (HP:0100614) | 2.76057977 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.72342329 |
| 59 | Purpura (HP:0000979) | 2.71594908 |
| 60 | Aneurysm (HP:0002617) | 2.71306568 |
| 61 | Periodontitis (HP:0000704) | 2.70990086 |
| 62 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.68103035 |
| 63 | Mitral valve prolapse (HP:0001634) | 2.63742352 |
| 64 | Fat malabsorption (HP:0002630) | 2.63113006 |
| 65 | Abnormal platelet volume (HP:0011876) | 2.62696071 |
| 66 | Atrophic scars (HP:0001075) | 2.62606304 |
| 67 | Joint laxity (HP:0001388) | 2.61567433 |
| 68 | Fragile skin (HP:0001030) | 2.61403731 |
| 69 | Broad ribs (HP:0000885) | 2.60164373 |
| 70 | Axonal loss (HP:0003447) | 2.59075194 |
| 71 | Biconcave vertebral bodies (HP:0004586) | 2.58255849 |
| 72 | Elbow flexion contracture (HP:0002987) | 2.58048465 |
| 73 | Increased cerebral lipofuscin (HP:0011813) | 2.55624544 |
| 74 | Recurrent skin infections (HP:0001581) | 2.55381917 |
| 75 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.54378117 |
| 76 | Abnormality of the lumbar spine (HP:0100712) | 2.52640190 |
| 77 | Nephritis (HP:0000123) | 2.52539570 |
| 78 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.51945835 |
| 79 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.51945835 |
| 80 | Abnormality of glycolipid metabolism (HP:0010969) | 2.51945835 |
| 81 | Skin nodule (HP:0200036) | 2.51281285 |
| 82 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.51210598 |
| 83 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.50659477 |
| 84 | Spontaneous abortion (HP:0005268) | 2.45076445 |
| 85 | Thrombocytosis (HP:0001894) | 2.44689088 |
| 86 | Autoimmune thrombocytopenia (HP:0001973) | 2.43853240 |
| 87 | Thrombophlebitis (HP:0004418) | 2.43490335 |
| 88 | Abnormality of methionine metabolism (HP:0010901) | 2.43157839 |
| 89 | Increased mean platelet volume (HP:0011877) | 2.42964621 |
| 90 | Hypoventilation (HP:0002791) | 2.42054474 |
| 91 | Abnormal platelet function (HP:0011869) | 2.39922422 |
| 92 | Impaired platelet aggregation (HP:0003540) | 2.39922422 |
| 93 | Pulmonary embolism (HP:0002204) | 2.39875229 |
| 94 | Mitral stenosis (HP:0001718) | 2.33795773 |
| 95 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.32899359 |
| 96 | Hyperammonemia (HP:0001987) | 2.32255223 |
| 97 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.30021371 |
| 98 | Abnormality of macrophages (HP:0004311) | 2.24359353 |
| 99 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23364853 |
| 100 | Petechiae (HP:0000967) | 2.22746354 |
| 101 | Conjunctival telangiectasia (HP:0000524) | 2.22187898 |
| 102 | Delayed cranial suture closure (HP:0000270) | 2.20478596 |
| 103 | Thoracic kyphosis (HP:0002942) | 2.19787619 |
| 104 | Urticaria (HP:0001025) | 2.19411117 |
| 105 | Joint stiffness (HP:0001387) | 2.18246188 |
| 106 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.18103255 |
| 107 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.17961281 |
| 108 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.17720604 |
| 109 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.17720604 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.17720604 |
| 111 | Spinal cord lesions (HP:0100561) | 2.16192581 |
| 112 | Syringomyelia (HP:0003396) | 2.16192581 |
| 113 | Shallow orbits (HP:0000586) | 2.16017054 |
| 114 | Hyperextensible skin (HP:0000974) | 2.15971576 |
| 115 | Arterial thrombosis (HP:0004420) | 2.15451181 |
| 116 | Ovoid vertebral bodies (HP:0003300) | 2.14615091 |
| 117 | Aortic regurgitation (HP:0001659) | 2.13976724 |
| 118 | Abnormality of the prostate (HP:0008775) | 2.11847347 |
| 119 | Hematochezia (HP:0002573) | 2.11481178 |
| 120 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.10820347 |
| 121 | Vertebral compression fractures (HP:0002953) | 2.10205403 |
| 122 | Microcytic anemia (HP:0001935) | 2.08369714 |
| 123 | Conjugated hyperbilirubinemia (HP:0002908) | 2.07178432 |
| 124 | Steatorrhea (HP:0002570) | 2.06690269 |
| 125 | Orchitis (HP:0100796) | 2.05112666 |
| 126 | Long toe (HP:0010511) | 2.04340117 |
| 127 | Amyloidosis (HP:0011034) | 2.03780494 |
| 128 | Cellulitis (HP:0100658) | 2.03735939 |
| 129 | Bruising susceptibility (HP:0000978) | 2.03673131 |
| 130 | Abnormality of iron homeostasis (HP:0011031) | 2.03074955 |
| 131 | Generalized amyotrophy (HP:0003700) | 2.02142076 |
| 132 | Cervical subluxation (HP:0003308) | 2.01788704 |
| 133 | Neonatal short-limb short stature (HP:0008921) | 2.00769109 |
| 134 | Premature rupture of membranes (HP:0001788) | 2.00762904 |
| 135 | Hyperbilirubinemia (HP:0002904) | 2.00552479 |
| 136 | Thoracolumbar scoliosis (HP:0002944) | 1.99764107 |
| 137 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99672905 |
| 138 | Mucopolysacchariduria (HP:0008155) | 1.99672905 |
| 139 | Esophageal varix (HP:0002040) | 1.99520108 |
| 140 | Ketosis (HP:0001946) | 1.99270726 |
| 141 | Abnormality of the acetabulum (HP:0003170) | 1.99026870 |
| 142 | Dysostosis multiplex (HP:0000943) | 1.98924286 |
| 143 | Gingivitis (HP:0000230) | 1.98499210 |
| 144 | Abnormality of skull ossification (HP:0002703) | 1.97921252 |
| 145 | Hypoglycemic coma (HP:0001325) | 1.97109172 |
| 146 | Achilles tendon contracture (HP:0001771) | 1.95253307 |
| 147 | Mediastinal lymphadenopathy (HP:0100721) | 1.94356721 |
| 148 | Nausea (HP:0002018) | 1.93213242 |
| 149 | Aplastic anemia (HP:0001915) | 1.92037392 |
| 150 | Cupped ribs (HP:0000887) | 1.91781111 |
| 151 | Abnormality of the frontal sinuses (HP:0002687) | 1.91510427 |
| 152 | Hepatocellular carcinoma (HP:0001402) | 1.89644233 |
| 153 | Venous abnormality (HP:0002624) | 1.88251284 |
| 154 | Disproportionate tall stature (HP:0001519) | 1.87265001 |
| 155 | Craniofacial hyperostosis (HP:0004493) | 1.87243900 |
| 156 | Interstitial pulmonary disease (HP:0006530) | 1.86753861 |
| 157 | Redundant skin (HP:0001582) | 1.86483591 |
| 158 | Wide anterior fontanel (HP:0000260) | 1.86166010 |
| 159 | Spastic diplegia (HP:0001264) | 1.86111130 |
| 160 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.85627570 |
| 161 | Osteolytic defects of the hand bones (HP:0009699) | 1.85627570 |
| 162 | Abnormality of the peritoneum (HP:0002585) | 1.81805803 |
| 163 | Wrist flexion contracture (HP:0001239) | 1.80238756 |
| 164 | Abnormal delivery (HP:0001787) | 1.79621476 |
| 165 | Abnormality of the Achilles tendon (HP:0005109) | 1.75938511 |
| 166 | Persistence of primary teeth (HP:0006335) | 1.72448709 |
| 167 | Flared iliac wings (HP:0002869) | 1.71925999 |
| 168 | Polycythemia (HP:0001901) | 1.70791858 |
| 169 | Asymmetric septal hypertrophy (HP:0001670) | 1.70289491 |
| 170 | Short clavicles (HP:0000894) | 1.67918622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KIT | 3.35973531 |
| 2 | MYLK | 2.85464434 |
| 3 | BLK | 2.68443369 |
| 4 | ERN1 | 2.55411412 |
| 5 | TEC | 2.45592156 |
| 6 | IRAK4 | 2.33577349 |
| 7 | TAOK3 | 2.31832834 |
| 8 | TYK2 | 2.30590066 |
| 9 | NEK9 | 2.28499630 |
| 10 | SIK1 | 2.23040010 |
| 11 | CSF1R | 2.19804650 |
| 12 | BTK | 2.18406830 |
| 13 | PRPF4B | 2.14284417 |
| 14 | TGFBR2 | 2.13889520 |
| 15 | TBK1 | 2.11529291 |
| 16 | FRK | 2.00596481 |
| 17 | PAK2 | 1.96780301 |
| 18 | MAP4K1 | 1.90706431 |
| 19 | JAK3 | 1.90534150 |
| 20 | IRAK3 | 1.87526444 |
| 21 | TRIB3 | 1.79419787 |
| 22 | FLT3 | 1.77875995 |
| 23 | CAMK1D | 1.75900898 |
| 24 | BCKDK | 1.68906181 |
| 25 | MAP2K3 | 1.64015320 |
| 26 | RIPK4 | 1.61803692 |
| 27 | IKBKE | 1.58261705 |
| 28 | PKN2 | 1.57556585 |
| 29 | JAK1 | 1.53439805 |
| 30 | PRKD2 | 1.49973383 |
| 31 | GRK5 | 1.45052110 |
| 32 | FGFR4 | 1.44326670 |
| 33 | TXK | 1.43595577 |
| 34 | MATK | 1.38558895 |
| 35 | RIPK1 | 1.36667424 |
| 36 | AKT3 | 1.36597347 |
| 37 | MAP3K14 | 1.36583471 |
| 38 | FGFR3 | 1.35420080 |
| 39 | IKBKB | 1.33993983 |
| 40 | PIK3CG | 1.32613641 |
| 41 | NTRK1 | 1.29895511 |
| 42 | MAP3K13 | 1.28505842 |
| 43 | LYN | 1.28336356 |
| 44 | TGFBR1 | 1.27282674 |
| 45 | TRPM7 | 1.20995447 |
| 46 | MUSK | 1.20941420 |
| 47 | ZAP70 | 1.17144340 |
| 48 | MOS | 1.15659966 |
| 49 | EPHA3 | 1.13377310 |
| 50 | CDC42BPA | 1.12918615 |
| 51 | DDR2 | 1.11430649 |
| 52 | CAMKK2 | 1.10518091 |
| 53 | SYK | 1.08797482 |
| 54 | ADRBK2 | 1.07864377 |
| 55 | CSK | 1.07432025 |
| 56 | ADRBK1 | 1.07195602 |
| 57 | HCK | 1.06106656 |
| 58 | TIE1 | 1.05587224 |
| 59 | FES | 1.04265253 |
| 60 | LRRK2 | 1.00689283 |
| 61 | GSK3A | 1.00600079 |
| 62 | ABL2 | 0.98712092 |
| 63 | JAK2 | 0.95420598 |
| 64 | BMPR2 | 0.94317327 |
| 65 | PTK2 | 0.94253836 |
| 66 | CDK6 | 0.93345519 |
| 67 | EEF2K | 0.91858315 |
| 68 | KDR | 0.89434383 |
| 69 | EIF2AK2 | 0.87852963 |
| 70 | LCK | 0.87326444 |
| 71 | NME2 | 0.84358758 |
| 72 | MAPK7 | 0.84321664 |
| 73 | PTK6 | 0.83255332 |
| 74 | MAPK11 | 0.81337985 |
| 75 | MAP3K6 | 0.80676010 |
| 76 | EPHB2 | 0.80473938 |
| 77 | MTOR | 0.79755470 |
| 78 | CAMK1G | 0.79204129 |
| 79 | ERBB4 | 0.77936508 |
| 80 | PRKG2 | 0.77426854 |
| 81 | MAPKAPK5 | 0.76851746 |
| 82 | RPS6KA2 | 0.76346924 |
| 83 | TTN | 0.75750178 |
| 84 | ITK | 0.74766912 |
| 85 | RPS6KA4 | 0.73605405 |
| 86 | PDPK1 | 0.72077822 |
| 87 | MST1R | 0.71911264 |
| 88 | TAOK2 | 0.71482381 |
| 89 | INSRR | 0.71394475 |
| 90 | GRK1 | 0.69967110 |
| 91 | MAPK4 | 0.69215271 |
| 92 | CHUK | 0.68878875 |
| 93 | SCYL2 | 0.68551137 |
| 94 | EPHB1 | 0.66301294 |
| 95 | PRKAA2 | 0.66057671 |
| 96 | PIM2 | 0.65179823 |
| 97 | ICK | 0.64947536 |
| 98 | RPS6KC1 | 0.64544969 |
| 99 | RPS6KL1 | 0.64544969 |
| 100 | IRAK1 | 0.64532656 |
| 101 | HIPK2 | 0.64062166 |
| 102 | MKNK1 | 0.63799750 |
| 103 | MAP3K3 | 0.60119752 |
| 104 | IRAK2 | 0.59940206 |
| 105 | STK38 | 0.59613471 |
| 106 | IGF1R | 0.59607845 |
| 107 | PDGFRA | 0.59337642 |
| 108 | MAP3K1 | 0.59234272 |
| 109 | YES1 | 0.56941086 |
| 110 | MARK2 | 0.56274578 |
| 111 | MAPKAPK2 | 0.55713456 |
| 112 | EGFR | 0.54388729 |
| 113 | NUAK1 | 0.53730753 |
| 114 | CDK12 | 0.53180935 |
| 115 | TNIK | 0.52974899 |
| 116 | PIM1 | 0.52868751 |
| 117 | MAP3K7 | 0.52474899 |
| 118 | CDK4 | 0.51368522 |
| 119 | ABL1 | 0.50892653 |
| 120 | RPS6KA6 | 0.49721950 |
| 121 | CAMKK1 | 0.49468691 |
| 122 | MAP3K5 | 0.49170745 |
| 123 | CDK8 | 0.48868146 |
| 124 | CAMK4 | 0.46874088 |
| 125 | EIF2AK3 | 0.46758972 |
| 126 | GRK7 | 0.46142370 |
| 127 | LATS2 | 0.45563234 |
| 128 | MAPK12 | 0.45344806 |
| 129 | PRKCD | 0.45330990 |
| 130 | STK10 | 0.44473742 |
| 131 | PAK4 | 0.44224802 |
| 132 | GRK6 | 0.44095065 |
| 133 | PRKD1 | 0.42726660 |
| 134 | PIK3CA | 0.38059444 |
| 135 | TNK2 | 0.37520864 |
| 136 | FGR | 0.36268566 |
| 137 | CLK1 | 0.35473272 |
| 138 | STK3 | 0.33845709 |
| 139 | PDGFRB | 0.33035566 |
| 140 | EIF2AK1 | 0.32676775 |
| 141 | DMPK | 0.31971329 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.13158809 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.75084966 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.62199187 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.21038969 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.82886788 |
| 6 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.48099866 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.45500108 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.36604983 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.05908660 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.05057460 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.99087725 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.97265145 |
| 13 | * Focal adhesion_Homo sapiens_hsa04510 | 1.90769603 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 1.83066688 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.67776362 |
| 16 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67734440 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.65942315 |
| 18 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.61456147 |
| 19 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.60607304 |
| 20 | Leishmaniasis_Homo sapiens_hsa05140 | 1.57583640 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55419651 |
| 22 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50669787 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.47983221 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.47786587 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.43812938 |
| 26 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.43588252 |
| 27 | * Malaria_Homo sapiens_hsa05144 | 1.41750316 |
| 28 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.41374724 |
| 29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.39206174 |
| 30 | Bladder cancer_Homo sapiens_hsa05219 | 1.37524652 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.37143417 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36425602 |
| 33 | ABC transporters_Homo sapiens_hsa02010 | 1.35851812 |
| 34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.34224959 |
| 35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.32985921 |
| 36 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.32248213 |
| 37 | Retinol metabolism_Homo sapiens_hsa00830 | 1.31334638 |
| 38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30097638 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.29968040 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.27137612 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 1.26095650 |
| 42 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25737983 |
| 43 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.21096311 |
| 44 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.20153148 |
| 45 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.16316440 |
| 46 | Legionellosis_Homo sapiens_hsa05134 | 1.15506586 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.13507504 |
| 48 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.12984096 |
| 49 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.09881698 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09302067 |
| 51 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.07355810 |
| 52 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.05971165 |
| 53 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.05560620 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03721262 |
| 55 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.03690854 |
| 56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.03439000 |
| 57 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.02756103 |
| 58 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.01798525 |
| 59 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.01392697 |
| 60 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.97655947 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.95797299 |
| 62 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.95748213 |
| 63 | * Melanoma_Homo sapiens_hsa05218 | 0.95703633 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.94643752 |
| 65 | Tuberculosis_Homo sapiens_hsa05152 | 0.94054476 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93031534 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91876481 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 0.88396462 |
| 69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.86537538 |
| 70 | Prostate cancer_Homo sapiens_hsa05215 | 0.86325933 |
| 71 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86210111 |
| 72 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.85322512 |
| 73 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.85106797 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.84284036 |
| 75 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.84140515 |
| 76 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.84012619 |
| 77 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.83745952 |
| 78 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.83071531 |
| 79 | Measles_Homo sapiens_hsa05162 | 0.82425955 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.82118321 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.79764804 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78792753 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77781074 |
| 84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.76594581 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76528011 |
| 86 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.76331542 |
| 87 | Glioma_Homo sapiens_hsa05214 | 0.76296323 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76245890 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75985528 |
| 90 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75438790 |
| 91 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75365567 |
| 92 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73404880 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72698193 |
| 94 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72563144 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.71906584 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70981413 |
| 97 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.70608371 |
| 98 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.70372820 |
| 99 | Phagosome_Homo sapiens_hsa04145 | 0.70021714 |
| 100 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.69727591 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.67000703 |
| 102 | Apoptosis_Homo sapiens_hsa04210 | 0.66193740 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65943113 |
| 104 | * Pathways in cancer_Homo sapiens_hsa05200 | 0.65845462 |
| 105 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65138995 |
| 106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64614946 |
| 107 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64128667 |
| 108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.63725804 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62972780 |
| 110 | Platelet activation_Homo sapiens_hsa04611 | 0.62823650 |
| 111 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62582418 |
| 112 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.61059007 |
| 113 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.60932084 |
| 114 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.60128155 |
| 115 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60126285 |
| 116 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.59977733 |
| 117 | Lysine degradation_Homo sapiens_hsa00310 | 0.59630275 |
| 118 | Influenza A_Homo sapiens_hsa05164 | 0.58953855 |
| 119 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58813884 |
| 120 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58467679 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58446455 |
| 122 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58308776 |
| 123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56673970 |
| 124 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.56171852 |
| 125 | Asthma_Homo sapiens_hsa05310 | 0.54589802 |
| 126 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53253587 |
| 127 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53222806 |
| 128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.52699214 |
| 129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.52308049 |
| 130 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.51669045 |
| 131 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.51472076 |
| 132 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.50935182 |
| 133 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.50471123 |
| 134 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.50248231 |
| 135 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.50044674 |
| 136 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.49928602 |
| 137 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.48620890 |
| 138 | * Renal cell carcinoma_Homo sapiens_hsa05211 | 0.47782811 |
| 139 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.47755499 |
| 140 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.47333845 |
| 141 | Prion diseases_Homo sapiens_hsa05020 | 0.46643100 |
| 142 | Salmonella infection_Homo sapiens_hsa05132 | 0.46583142 |
| 143 | Allograft rejection_Homo sapiens_hsa05330 | 0.46272607 |
| 144 | Amoebiasis_Homo sapiens_hsa05146 | 0.45602369 |
| 145 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.45436767 |
| 146 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.45093632 |
| 147 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45082438 |
| 148 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.44660607 |
| 149 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.44039510 |
| 150 | Galactose metabolism_Homo sapiens_hsa00052 | 0.42739192 |
| 151 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42556138 |
| 152 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.42553776 |
| 153 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42152953 |
| 154 | Hepatitis C_Homo sapiens_hsa05160 | 0.41572647 |
| 155 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.40297213 |
| 156 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39264088 |
| 157 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37219215 |
| 158 | Hepatitis B_Homo sapiens_hsa05161 | 0.35665144 |

